Morocco latest patents query
The latest invention patents collect the data information of Morocco invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
PROCESS FOR PRODUCING A 4-METHOXY PYRROLUS DERIVATIVE
UndeterminedMA53673A
Owner:DAEWOONG PHARM CO LTD
JAK kinase sulfone inhibitors (pyrazolopyrimidine) and their uses
UndeterminedMA56518A
Owner:F HOFFMANN LA ROCHE & CO AG
BIOCOMPATIBLE ADHESIVES AND THEIR METHODS OF USE
UndeterminedMA44490A
Owner:PRESIDENT & FELLOWS OF HARVARD COLLEGE
COMBINED TREATMENTS INCLUDING THE ADMINISTRATION OF IMIDAZOPYRAZINONES
UndeterminedMA46621A
Owner:H LUNDBECK AS
Anti-PD1 antibodies and their uses
InactiveMA46708Aenhance immune response
Owner:JOUNCE THERAPEUTICS INC
METHOD FOR PREVENTING INFECTION BY A PLANT VIRUS
Owner:ISHIHARA SANGYO KAISHA LTD
Dosage and administration Anti-egfr therapeutics
UndeterminedMA39599A
Owner:MERRIMACK PHARMACEUTICALS INC
VEHICLE GLASS, VEHICLE GLASS ASSEMBLY AND ITS MANUFACTURING PROCESS
UndeterminedMA55768A
Owner:SAINT GOBAIN VITRAGE SA
Bispecific antibodies that bind particularly to PD1 and LAG3
ActiveMA49038A
Owner:F HOFFMANN LA ROCHE & CO AG
NEW PEPTIDES AND PEPTIDE COMBINATIONS FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS (SEQ ID 243 - SPC25-001)
UndeterminedMA43440A
Owner:IMMATICS BIOTECHNOLOGIES GMBH
PROCESS FOR PRODUCING AN ELECTROCATELALYSER
Owner:HYMETH APS
GLIADINE DEGRADATION PROCESS TO OBTAIN GLUTEN-FREE FLOUR
UndeterminedMA49546A
Owner:GONZALEZ DE LA TORRE JAVIER
Octreotide intended for oral administration in combination with other therapeutic agents
UndeterminedMA41159A
Owner:CHIASMA INC +2
TREATMENT METHODS FOR CANCER RESISTANT TO CDK4 / 6 INHIBITORS
UndeterminedMA54388A
Owner:RADIUS PHARMACEUTICALS INC
PLASTIC OPENING THAT RETAINS ITS FUNCTION OF SEALANTING THE BOX OPENING IN CASE OF IMPACT
UndeterminedMA45398A
Owner:COMPAGNIE PLASTIC OMNIUM SA
Beta-3 Adrenergetic Receptor Modulators Useful for the Treatment and Prevention of Disorders Associated with the Beta-3 Receptor
UndeterminedMA45150A
Owner:ARENA PHARMACEUTICALS INC
OXAZOLINE PSEUDODIMERS, PHARMACEUTICAL COMPOSITIONS AND CORRESPONDING USES
UndeterminedMA44859A
Owner:PURDUE PHARMA LP
Feeding livestock with low doses of algae to produce high levels of omega-3 in beef
UndeterminedMA40953A
Owner:SMITH DONALD M
Bispecific anti-PCRV antibodies and blood products for the treatment of bronchiectasis
UndeterminedMA71321A
Owner:ASTRAZENECA AB
Pharmaceutical compositions intended for the treatment of diseases related to the transmembrane conductance regulator of cystic fibrosis
ActiveMA55774A
Owner:VERTEX PHARMACEUTICALS INC
ANTISENSE-INDUCED INCLUSION OF EXON 2 IN AN ACID ALPHA-GLUCOSIDASE
UndeterminedMA41759A
Owner:MURDOCH UNIV +1
Artificially modified antigen-presenting cells for the expansion of intratumoral lymphocyte infiltration
UndeterminedMA46668A
Owner:IOVANCE BIOTHERAPEUTICS INC
HETEROCYCLIC COMPOUNDS USEFUL AS DUAL ATX / CA INHIBITORS
UndeterminedMA49879A
Owner:F HOFFMANN LA ROCHE & CO AG
NETWORK OF PONTOONS FOR SOLAR PANELS AND ASSOCIATED CONNECTION MODULES
UndeterminedMA50809A
Owner:OCEANS OF ENERGY BV
POLYTHERAPY USING ADOPTIVE CELL THERAPY AND A CHECKPOINT INHIBITOR
UndeterminedMA54118A
Owner:CELGENE CORP
METHODS FOR MASS SPECTROMETRY ANALYSIS OF MODIFIED CELLULAR COMPOSITIONS
UndeterminedMA53612A
Owner:JUNO THERAPEUTICS INC
Human antibodies directed against bone morphogenetic protein 6
UndeterminedMA56203A
Owner:REGENERON PHARMACEUTICALS INC
GRAPHENE-BASED HEAT-DISSIPATING LED LAMP
UndeterminedMA49418A
Owner:HUZHOU MINGSHUO OPTOELECTRONICS TECH CO LTD +1
METHOD AND APPARATUS FOR PREPARING AN OLIVE OIL WITH A HIGH POLYPHENOL CONTENT
UndeterminedMA50226A
Owner:LEVIUS VITA FOODS SRL
Nitisinone dosing regimens for the treatment of alkaptonuria
UndeterminedMA39918A
Owner:SWEDISH ORPHAN BIOVITRUM INT
BICYCLIC ENONE CARBOXYLATES USED AS CARRIER MODULATORS AND THEIR USES
UndeterminedMA52240A
Owner:NIROGY THERAPEUTICS INC
BODY INFORMATION ANALYSIS DEVICE AND ITS REDNESS ANALYSIS METHOD
UndeterminedMA47134A
Owner:CAL COMP BIG DATA INC
4,6-DIHYDROPYRROLO[3,4-C]PYRAZOLE-5(1H)-CARBONITRILE DERIVATIVES FOR CANCER TREATMENT
UndeterminedMA43745A
Owner:MISSION THERAPEUTICS LTD
TANK WITH PIPE PREVENTING LIQUID FUEL FROM FLYING TO A FUEL VAPOR STORAGE DEVICE
ActiveMA46410A
Owner:PSA AUTOMOBILES SA
METHODS AND APPARATUS FOR ELASTIC DEACTIVATION IN A LAMINATE
UndeterminedMA46382A
Owner:JOA CURT G INC
HER2-TARGETING ANTIGEN-BINDING MOLECULES INCLUDING 4-1BBL
UndeterminedMA52182A
Owner:F HOFFMANN LA ROCHE & CO AG
COLD-ROLLED, HEAT-TREATED STEEL SHEET AND ITS MANUFACTURING PROCESS
ActiveMA54523A
Owner:ARCELORMITTAL SA
USING THE SIZE OF FREE DNA FRAGMENTS IN CELLS TO DETERMINE COPY NUMBER VARIATIONS
UndeterminedMA52131A
Owner:VERINATA HEALTH INC
Pharmaceutical composition including empagliflozin and its uses
UndeterminedMA43709A
Owner:BOEHRINGER INGELHEIM INT GMBH
A COMBINATION OF ANTI-PD-1 ANTIBODIES AND RADIATION TO TREAT CANCER
ActiveMA44978AImprove anti-tumor efficacyreduce lesions
Owner:REGENERON PHARMACEUTICALS INC
BACTERIAL MINICELLS FOR THE ADMINISTRATION OF NUCLEIC ACID ADJUVANTS AND THEIR METHODS OF USE
UndeterminedMA46469A
Owner:ENGENEIC MOLECULAR DELIVERY PTY LTD
PROGESTERONE RECEPTOR MODULATOR (SPRM) MEDICINES (11.BETA.,17.BETA.)-17-HYDROXY-11-[4-(METHYLSULPONYL)PHENYL]-17-(PENTAFLUOROETHYL)ESTRA-4,9-DIEN-3-ONE
UndeterminedMA43691A
Owner:BAYER PHARMA AG
METHOD FOR PREDICTING THE THERAPEUTIC EFFECT OF AN LSD1 INHIBITOR BASED ON INSM1 EXPRESSION
UndeterminedMA50518A
Owner:TAIHO PHARMA CO LTD
METHODS FOR DETERMINING THE SEX OF AVIAN EMBRYOS IN UNHATCHED EGGS AND CORRESPONDING MEANS
UndeterminedMA48783A
Owner:EGGXYT LTD
METHOD AND DEVICE FOR APPLYING INSULATION TO BUILDINGS
UndeterminedMA42528A
Owner:HOLZWEBER MARIA ELISABETH +1
FLOTATION PROCESS FOR THE PROCESSING OF PHOSPHATE ORES
UndeterminedMA47115A
Owner:AKZO NOBEL CHEMICALS INTERNATIONAL BV
COMPOUNDS EXHIBITING MUSCARINIC RECEPTOR ANTAGONIST AND BETA-2 ADRENERGIC RECEPTOR AGONIST ACTIVITY
UndeterminedMA41492A
Owner:CHIESI FARMACEUTICI SPA
METHOD FOR SUPPLYING AN BACKUP POWER MODULE AND A LOW-ENERGY BACKUP POWER MODULE
UndeterminedMA45572A
Owner:TM TECHNOLOGIE SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA
RESPIRATORY VIRUS VACCINES
Owner:MODERNATX INC
SAFE AND EFFECTIVE METHOD FOR TREATMENT OF LUPUS WITH AN ANTI-IL12 / IL23 ANTIBODY
UndeterminedMA54562A
Owner:JANSSEN BIOTECH INC
METHOD AND DEVICE FOR STRIPPING A CABLE COMPRISING A MULTI-LAYER SHEATH
ActiveMA46547A
Owner:KOMAX HOLDING
Recombinant HVT vectors expressing multiple avian pathogen antigens, and vaccines containing them
UndeterminedMA49874A
Owner:BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC
METHODS FOR DETECTING PARTICLES PRESENT IN A CELLULAR COMPOSITION
UndeterminedMA52114A
Owner:JUNO THERAPEUTICS INC
ATR KINASE INHIBITOR BAY1895344 INTENDED FOR USE IN THE TREATMENT OF A HYPERPROLIFERATIVE DISEASE
UndeterminedMA54928A
Owner:BAYER AG
N-ACYL-(4-[(4-ARYL-PHENYL)SULFONYLMETHYL]PIPERIDINE) COMPOUNDS AND THEIR THERAPEUTIC USE
UndeterminedMA55713A
Owner:MODERN BIOSCI LTD
BIOVOILE FOR THE TREATMENT OF WOUNDS AND BURNS
UndeterminedMA53350A
Owner:ASOCIACION DE INVESTIGACION DE LA INDA TEXTIL (AITEX)
PROCESSES FOR MANUFACTURING HIGH-PROTEIN GREEK YOGURT USING MEMBRANE SYSTEMS BEFORE AND AFTER FERMENTATION
UndeterminedMA49834A
Owner:FAIRLIFE LLC
OLIVE MARGIN PRODUCTS, THEIR PRODUCTION PROCESS AND USES
UndeterminedMA45247A
Owner:UNIVERSIDADE DO PORTO
DOSAGE AND EFFECT OF A C5A ANTAGONIST WITH ANCA-ASSOCIATED VASCULITIS
UndeterminedMA52808A
Owner:CHEMOCENTRYX INC
2,4-DIOXO-QUINAZOLINE-6-SULPHONAMIDE DERIVATIVES AS PARG INHIBITORS
UndeterminedMA41140A
Owner:CANCER RESEARCH TECHNOLOGY LTD
INHIBITEURS D'OXAZINE MONOACYLGLYCEROL LIPASE (MAGL)
InactiveMA52072A
Owner:F HOFFMANN LA ROCHE & CO AG
TREATMENT METHODS FOR S1P1 RECEPTOR-ASSOCIATED DISORDERS
UndeterminedMA52778A
Owner:ARENA PHARMACEUTICALS INC
SYSTEMS AND METHODS FOR CHARGING ONE OR MORE ELECTRONIC DEVICES
UndeterminedMA49776A
Owner:FLI CHARGE LLC
PROCESS FOR THE MANUFACTURE OF A SOLUTION OF AN ALKALINE-EARTH HYDROGEN CARBONATE
UndeterminedMA41410A
Owner:OMYA INT AG
ARTIFICIAL TURF INCLUDING AN AGGLOMERATE FILLER ELEMENT
UndeterminedMA45663A
Owner:POLYTEX SPORTBELAEGE PROD GMBH
Conveying and holding device for glass sheets, particularly in a washing plant
UndeterminedMA44615A
Owner:SAINT GOBAIN VITRAGE SA
2,4-DIAMINO-QUINOLINE SUBSTITUTED AS A NOVEL ANTICANCER AGENT
Owner:GENOSCIENCE PHARMA SAS
COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROCOGNITIVE DISORDERS
UndeterminedMA54880A
Owner:AVROBIO INC
Wind turbine blade equipped with a noise reduction device
UndeterminedMA48932A
Owner:LM WIND POWER INT TECH II APS
FIXING CLIP FOR PHOTOVOLTAIC FRAME WITH INSERT MOUNTING AND THEN SLIDE INTO A SLOT IN A SUPPORT WALL
ActiveMA49481A
Owner:A RAYMOND & CO SCS
Pharmaceutical compositions containing DGLA acid and their use
UndeterminedMA52644A
Owner:DS BIOPHARMA LTD
CELL-PENETRATING PEPTIDES FOR ANTISENSE ADMINISTRATION
UndeterminedMA50834A
Owner:MASSACHUSETTS INST OF TECH +1
PYRIDINE AND SUBSTITUTED PYRIMIDINES AND THEIR USE AS GLUN2B RECEIVER MODULATORS
UndeterminedMA52244A
Owner:JANSSEN PHARMA NV
FLOOR BOARDS WITH A CORE CONTAINING CALCIUM CARBONATE AND THEIR MANUFACTURING PROCESSES
UndeterminedMA51704A
Owner:I4F LICENSING NV
Method and system for homogenous thermoplastic seat back assembly
UndeterminedMA39944A
Owner:RELIANT WORLDWIDE PLASTICS LLC
SPIRO-SULFONAMIDE DERIVATIVES AS INHIBITORS OF MYELOID LEUKEMIA PROTEIN -1 (MCL-1)
UndeterminedMA54157A
Owner:PRELUDE THERAPEUTICS INC
REGAZING TERMINAL AND METHOD FOR OPERATING SUCH A REGAZING TERMINAL
UndeterminedMA46029A
Owner:SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ BV
METHOD FOR CONTROLLING A COOKING APPLIANCE AND ASSOCIATED COOKING APPLIANCE
UndeterminedMA40356A
Owner:GRP BRANDT
Composition of a binder based on plant fibers and mineral fillers, its preparation and use
UndeterminedMA43434A
Owner:CENT TECHN IND DIT CENT TECHN +1
Synergistic composition comprising propolis and carnosic acid for use in the treatment and prevention of infections caused by Cryptococcus neoformans fungal species
InactiveMA44829A
Owner:VITALGAIA ESPANA
MOUNTING SUPPORT FOR MOUNTING A WALL COVERING AND ASSOCIATED METHOD
UndeterminedMA49530A
Owner:VBG BVBA
Oral pharmaceutical composition of isotretinoin
UndeterminedMA44264A
Owner:SUN PHARMACEUTICAL INDUSTRIES LTD
COMPOSITION INTENDED FOR USE IN THE TREATMENT OF SYMPTOMS OF EXTRA-SOPHAGEAL GASTRIC REFLUX
UndeterminedMA48955A
Owner:DRUGS MINERALS & GENERICS ITAL S R L IN FORMA ABBREVIATA D M G ITAL SRL
A SAFE AND EFFECTIVE METHOD FOR TREATMENT OF ULCERATIVE COLITIS WITH AN ANTI-IL12 / IL23 ANTIBODY
ActiveMA55140A
Owner:JANSSEN BIOTECH INC
CRYSTALLINE AND SALINE FORMS OF AN ORGANIC COMPOUND AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS
UndeterminedMA54541A
Owner:LES LAB SERVIER SA
Anti-TIM-3 antibodies for combination with anti-PD-1 antibodies
UndeterminedMA48604A
Owner:ELI LILLY & CO +1
5,6 FUSION BICYCLIC COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES
UndeterminedMA50495A
Owner:NOVARTIS AG
NEW PEPTIDES AND PEPTIDE COMBINATIONS INTENDED FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
UndeterminedMA44999A
Owner:IMMATICS BIOTECHNOLOGIES GMBH
Antigen-binding molecules capable of binding to CD3 and CD137, but not simultaneously
UndeterminedMA53742A
Owner:CHUGAI PHARMA CO LTD
Rail transport dump loop system for conveying bulk materials
UndeterminedMA40410A
Owner:RAIL VEYOR TECH GLOBAL
PATHOGEN CONTROL COMPOSITIONS AND THEIR USES
UndeterminedMA52637A
Owner:FLAGSHIP PIONEERING INNOVATIONS VI LLC
Charging circuit and mobile terminal
UndeterminedMA40578A
Owner:GUANGDONG OPPO MOBILE TELECOMMUNICATIONS CORP LTD